Results 1 to 10 of about 73,504 (266)

Factors associated with willingness to accept pneumococcal vaccine based on the Health Belief Model among the elderly (≥60 years) living in Klang Valley, Malaysia [PDF]

Human Vaccines & Immunotherapeutics
Understanding health behavior using the Health Belief Model (HBM) helps formulate strategies to improve the willingness, thereby increasing the acceptance of pneumococcal vaccination among the elderly.
Muhammad Faiz Mohd Hisham, Chandrashekhar T. Sreeramareddy   +1 more
doaj   +2 more sources

Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development [PDF]

Vaccines
Pneumococcal vaccines are a cornerstone for the prevention of pneumococcal diseases, reducing morbidity and mortality in children and adults worldwide.
Kristen Feemster, William P. Hausdorff, Natalie Banniettis, Heather Platt, Priscilla Velentgas, Alejandra Esteves-Jaramillo, Robert L. Burton, Moon H. Nahm, Ulrike K. Buchwald   +8 more
doaj   +2 more sources

Pneumococcal carriage in sub-Saharan Africa--a systematic review. [PDF]

, 2014
BACKGROUND: Pneumococcal epidemiology varies geographically and few data are available from the African continent. We assess pneumococcal carriage from studies conducted in sub-Saharan Africa (sSA) before and after the pneumococcal conjugate vaccine (PCV)
A Fenoll, A Kacou-N'Douba, A Kacou-N'douba, A Roca, A von Gottberg, A Woolfson, A Yomo, AB Brueggemann, AH Skalet, AK Rowe, Andrew Hall, B Frederiksen, B Oppenheim, BM Gray, BM Gray, C Levy, Caroline L. Trotter, Christian Bottomley, CL Trotter, D Bogaert, D Hansman, DB Blossom, DM Denno, DM Mwenya, DR Feikin, DR Feikin, E Varon, Effua Usuf, ES Donkor, EV Millar, G Regev-Yochay, GA Mackenzie, H Faden, H Rinta-Kokko, H Smith-Vaughan, HL Johnson, HT Vu, ID Rusen, JA Scott, JAG Scott, JD Kellner, JR Scott, KA Robinson, KL O'Brien, KL O'Brien, KP Klugman, L Marcus, L Pemba, LC Bere, LM McNally, M Antonio, M Guevara, M Mthwalo, MF Cotton, MK Darboe, MK Darboe, ML Joloba, MO Ota, MR Capeding, MR Jacobs, MW Mureithi, N Lloyd-Evans, N Mbelle, NOA Nwachukwu, O Abdullahi, O Abdullahi, PC Hill, PC Hill, PC Hill, PL Ho, PW Roche, R Dagan, RA Adegbola, RE Huebner, RE Huebner, Richard A. Adegbola, RK Syrjanen, RM Robins-Browne, RN Ndip, S Haug, S Yang, SB Gordon, SK Obaro, SK Obaro, SL Batt, SL Kaplan, SR Williams, SS Huang, WM Nyandiko, X Valles, YB Cheung, YT Kandakai-Olukemi   +91 more
core   +24 more sources

Influenza and pneumococcal vaccine hesitancy in the elderly population: results from two representative surveys in Germany. [PDF]

BMC Public Health
Heinemeier D, Schmid P, Eitze S, Betsch C, Vaccination60+ study group.   +4 more
europepmc   +3 more sources

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults

Microorganisms, 2021
Pneumococcal disease is one of the most common and severe vaccine-preventable diseases (VPDs). Despite the advances in antimicrobial treatment, pneumococcal disease still remains a global burden and exhibits a high mortality rate among people of all ages
Nobuhiro Asai, Hiroshige Mikamo
doaj   +1 more source

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.

PLoS ONE, 2022
Pneumococcal conjugate vaccines reduce the burden of invasive pneumococcal disease, but the sustained effect of these vaccines can be diminished by an increase in disease caused by non-vaccine serotypes.
Sweta M Patel, Yazdani B Shaik-Dasthagirisaheb, Morgan Congdon, Rebecca R Young, Mohamed Z Patel, Tiny Mazhani, Sefelani Boiditswe, Tirayaone Leburu, Kwana Lechiile, Tonya Arscott-Mills, Andrew P Steenhoff, Kristen A Feemster, Samir S Shah, Coleen K Cunningham, Stephen I Pelton, Matthew S Kelly   +15 more
doaj   +3 more sources

A brief history of and future prospects for pneumococcal vaccination in Malaysia

Pneumonia, 2023
Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme.
Alex J. J. Lister, Evelin Dombay, David W. Cleary, Lokman H. Sulaiman, Stuart C. Clarke   +4 more
doaj   +1 more source

Pneumococcal vaccine [PDF]

Postgraduate Medical Journal, 1997
Summary Streptococcus pneumoniae is a frequent cause of pneumonia and meningitis. This article looks at the pneumococcal vaccine, its uses, efficacy, and adverse effects and how vaccination may be improved. We also look at the role of the new conjugate vaccines.
K L, Hattotuwa, C R, Hind
openaire   +2 more sources

Distribution and Variation of Serotypes and Pneumococcal Surface Protein A Clades of Streptococcus pneumoniae Strains Isolated From Adult Patients With Invasive Pneumococcal Disease in Japan

Frontiers in Cellular and Infection Microbiology, 2021
Pneumococcal surface protein A (PspA) is a surface protein of Streptococcus pneumoniae that may be a candidate antigen for new pneumococcal vaccines.
Bin Chang, Yuki Kinjo, Yuki Kinjo, Yuki Kinjo, Masatomo Morita, Kosuke Tamura, Hiroshi Watanabe, Yoshinari Tanabe, Koji Kuronuma, Jiro Fujita, Kengo Oshima, Takaya Maruyama, Shuichi Abe, Kei Kasahara, Junichiro Nishi, Tetsuya Kubota, Makoto Ohnishi, Shigeru Suga, Kazunori Oishi   +18 more
doaj   +1 more source

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults. [PDF]

, 2010
BACKGROUND: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa.
French, N, Gilks, CF, Gordon, SB, Longwe, H, Molyneux, ME, Mwafulirwa, G, Mwaiponya, M, Mwalukomo, T, White, SA, Zijlstra, EE   +9 more
core   +4 more sources